M, V. R.; Gnk, G.; B, B.; Jagadeesan, R.; M R, P. K. Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration: Risk Assessment of CGT and PC Exclusivity Drugs. AMM 2022, 68.